5 New Drug Approvals the FDA Gave Top Priority
The U.S. Food and Drug Administration's made it clear that granting a priority review to an application isn't exactly the same thing as...
Disease-causing protein in cystic fibrosis has ancient roots in sea lamprey
The oldest known ortholog of the ion channel that is defective in patients with cystic fibrosis arose approximately 450 million years ago...
This 3-drug combo can improve lungs affected by cystic fibrosis
A phase three clinical trial conducted by UT Southwestern led to the conclusion that a three-drug blend could enhance lung functions and...
Long-awaited cystic fibrosis drug could turn deadly disease into a manageable condition
A new cystic fibrosis therapy dramatically improved patients’ lung function and showed clear signs of targeting the genetic root of the...
The surprising drugs that could help curb depression, according to new study -Some aren't convin
A new study has found that painkillers, statins and fish oils may help curb depression, especially if taken with antidepressants. The...
Cystic fibrosis carriers at increased risk of digestive symptoms
Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to...
First Patients Dosed in Trial Testing MS1819-SD Plus PERT for CF-related Severe EPI, AzurRX Says
AzurRx BioPharma has started dosing patients in a Phase 2 clinical trial assessing its investigational therapy MS1819-SD in combination...
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Vertex Pharmaceuticals on Monday won approval for its fourth treatment for cystic fibrosis, a combination drug that extends a new form of...
Prevalence and characterization of chronic rhinosinusitis in patients with non–cystic fibrosis bronc
In this retrospective cohort study, researchers identified the prevalence of chronic rhinosinusitis (CRS) among bronchiectasis patients...
CF patients experience improved lung health with lumacaftor-ivacaftor but with caveats
In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI), the combination drug appears to improve lung...
